000 | 01573 a2200445 4500 | ||
---|---|---|---|
005 | 20250514225058.0 | ||
264 | 0 | _c20050629 | |
008 | 200506s 0 0 eng d | ||
022 | _a0019-5847 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGanapati, R | |
245 | 0 | 0 |
_aReactions and their management. _h[electronic resource] |
260 |
_bJournal of the Indian Medical Association _cDec 2004 |
||
300 |
_a688-90, 692, 694 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aArthritis _xchemically induced |
650 | 0 | 4 |
_aCicatrix _xchemically induced |
650 | 0 | 4 |
_aClofazimine _xadverse effects |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug-Related Side Effects and Adverse Reactions |
650 | 0 | 4 |
_aEdema _xchemically induced |
650 | 0 | 4 |
_aErythema _xchemically induced |
650 | 0 | 4 |
_aErythema Nodosum _xchemically induced |
650 | 0 | 4 |
_aFoot _xpathology |
650 | 0 | 4 |
_aGlucocorticoids _xadverse effects |
650 | 0 | 4 |
_aHand _xpathology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypersensitivity _xetiology |
650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
650 | 0 | 4 |
_aLeprosy _xdrug therapy |
650 | 0 | 4 |
_aLymphadenitis _xchemically induced |
650 | 0 | 4 |
_aNeuritis _xchemically induced |
650 | 0 | 4 |
_aParalysis _xchemically induced |
650 | 0 | 4 |
_aPrednisolone _xadverse effects |
650 | 0 | 4 |
_aSkin _xdrug effects |
650 | 0 | 4 |
_aThalidomide _xadverse effects |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aPai, V V | |
773 | 0 |
_tJournal of the Indian Medical Association _gvol. 102 _gno. 12 _gp. 688-90, 692, 694 |
|
999 |
_c15537310 _d15537310 |